Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2018 1
2019 2
2020 3
2021 1
2022 6
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer.
Allouchery M, Lombard T, Martin M, Rouby F, Sassier M, Bertin C, Atzenhoffer M, Miremont-Salame G, Perault-Pochat MC, Puyade M; French Network of Regional Pharmacovigilance Centers. Allouchery M, et al. Among authors: atzenhoffer m. J Immunother Cancer. 2020 Dec;8(2):e001622. doi: 10.1136/jitc-2020-001622. J Immunother Cancer. 2020. PMID: 33428586 Free PMC article.
Vaccines and Bell's palsy: A narrative review.
Bertin B, Grenet G, Pizzoglio-Billaudaz V, Lepelley M, Atzenhoffer M, Vial T. Bertin B, et al. Among authors: atzenhoffer m. Therapie. 2022 Aug 1:S0040-5957(22)00137-8. doi: 10.1016/j.therap.2022.07.009. Online ahead of print. Therapie. 2022. PMID: 36038397 Free PMC article.
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
Moulis G, Crickx E, Thomas L, Massy N, Mahévas M, Valnet-Rabier MB, Atzenhoffer M, Michel M, Godeau B, Bagheri H, Salvo F; French Covigilance COVID-19 Vaccine-ITP Study Group. Moulis G, et al. Among authors: atzenhoffer m. Blood. 2022 Apr 21;139(16):2561-2565. doi: 10.1182/blood.2022015470. Blood. 2022. PMID: 35446373 Free PMC article. No abstract available.
Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database.
Martin M, Nguyen HM, Beuvon C, Bene J, Palassin P, Atzenhoffer M, Rouby F, Sassier M, Pérault-Pochat MC, Roblot P, Allouchery M, Puyade M; French Network of Regional Pharmacovigilance Centers. Martin M, et al. Among authors: atzenhoffer m. Cancers (Basel). 2022 Oct 14;14(20):5030. doi: 10.3390/cancers14205030. Cancers (Basel). 2022. PMID: 36291814 Free PMC article.
[COVID-19 and adenovirus vaccines: French experience of enhanced pharmacovigilance].
Massy N, Atzenhoffer M, Boulay C, Pecquet PE, Ledys F, Cracowski JL, Masmoudi K, Lepelley M, Gras-Champel V. Massy N, et al. Among authors: atzenhoffer m. Therapie. 2023 Jan 21:S0040-5957(23)00022-7. doi: 10.1016/j.therap.2023.01.005. Online ahead of print. Therapie. 2023. PMID: 36759287 Free PMC article. French.
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.
Velev M, Baroudjian B, Pruvost R, De Martin E, Laparra A, Babai S, Teysseire S, Danlos FX, Albiges L, Bernigaud C, Benderra MA, Pradère P, Zaidan M, Decroisette C, Fallah F, Matergia G, Lavaud P, Jantzem H, Atzenhoffer M, Buyse V, Ammari S, Robert C, Champiat S, Messayke S, Marabelle A, Guettier C, Lebbe C, Lambotte O, Michot JM. Velev M, et al. Among authors: atzenhoffer m. Eur J Cancer. 2023 Jan;179:28-47. doi: 10.1016/j.ejca.2022.11.001. Epub 2022 Nov 12. Eur J Cancer. 2023. PMID: 36473326
13 results